Two Lots of Blood Pressure Medicine Recalled: Is Yours Affected?
Two types of quinapril and hydrochlorothiazide tablets made by Aurobindo Pharma USA are being recalled because they contain too-high levels of nitrosamines. These compounds are commonly found in water and foods — including meats, dairy products and vegetables in lower levels — but may increase the risk of cancer if people are exposed to them above acceptable levels over long periods of time. This is according to the voluntary recall from Aurobindo, which was posted by the US Food and Drug Administration.
Quinapril and hydrochlorothiazide are used to treat hypertension, or high blood pressure. Two lots of Aurobindo’s 20 mg/12.5 mg are included in the recall, both with expiration dates through January 2023, and the specific lot numbers can be found in the recall announcements on Oct. 25. The tablets are pink-colored and round, with “D” printed on one side and “19” on the other side.
If you have this medication, you should talk with your doctor before you stop taking it, the notice posted by the FDA said. Untreated high blood pressure can raise the risk of stroke, heart attack and other serious health issues or medical emergencies, so you should discuss the risks and benefits of finding another medication.
The hypertension medication label is provided in the recall.
FDA
To date, Aurobindo said, it hasn’t received any reports of adverse events related to the recall. Consumers with medical questions about the recall can contact the company at 866-850-2876 (option 2) or email Aurobindo at pvg@aurobindousa.com. For questions about
:format(webp)/cdn.vox-cdn.com/uploads/chorus_asset/file/24186866/Screenshot_2022_11_10_at_19.15.05.png)
:format(webp)/cdn.vox-cdn.com/uploads/chorus_asset/file/24186868/Screenshot_2022_11_10_at_19.15.25.png)
